Jash Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 21-06-2024
- Paid Up Capital ₹ 1.00 Cr
as on 21-06-2024
- Company Age 19 Year, 5 Days
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 17.65 Cr
as on 21-06-2024
- Revenue 23.51%
(FY 2021)
- Profit -4.44%
(FY 2021)
- Ebitda 122.74%
(FY 2021)
- Net Worth 211.88%
(FY 2021)
- Total Assets 16.42%
(FY 2021)
About Jash Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹17.65 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mudassar Makandar and Nazia Makandar serve as directors at the Company.
- CIN/LLPIN
U24239MH2005PTC158290
- Company No.
158290
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2005
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Jash Pharma Private Limited offer?
Jash Pharma Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Cardiovascular Drugs & Medication, Diabetes Medicine, Anti Infective Drugs & Medicines, Antibacterial Drugs, Antibiotic Tablets & Capsules, Tetracycline Hydrochloride Tablet, Pharmaceutical Syrup, Multivitamin Syrup & Drops.
Who are the key members and board of directors at Jash Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nazia Makandar  | Director | 21-Feb-2024 | Current |
| Mudassar Makandar | Director | 26-Nov-2019 | Current |
Financial Performance of Jash Pharma.
Jash Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 23.51% increase. The company also saw a slight decrease in profitability, with a 4.44% decrease in profit. The company's net worth Soared by an impressive increase of 211.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jash Pharma?
Unlock access to Jash Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Vashishth Tech Enterprise Private LimitedActive 9 years 7 monthsMudassar Makandar and Nazia Makandar are mutual person
- Derive Tours And Travels Private LimitedActive 8 years 7 months
Mudassar Makandar and Nazia Makandar are mutual person
- Amm Call-Connect Private LimitedActive 12 years 5 months
Mudassar Makandar and Nazia Makandar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Jul 2014 | ₹7.10 Cr | Satisfied |
Janata Sahakari Bank Ltd Pune Creation Date: 22 Jul 2014 | ₹6.75 Cr | Satisfied |
Indian Bank Creation Date: 18 Jan 2007 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Jash Pharma?
Jash Pharma has a workforce of 27 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jash Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jash Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
